We are live on ! Find out more
CCP

Clough Capital Partners Portfolio holdings

AUM $1.23B
1-Year Est. Return 51.32%
This Fund
S&P 500
This Quarter Est. Return
+5.01%
1 Year Est. Return
+51.32%
3 Year Est. Return
+175.14%
5 Year Est. Return
+243.7%
10 Year Est. Return
+1,533.05%
AUM
$1.44B
AUM Growth
-$134M
Cap. Flow
-$187M
Cap. Flow %
-12.99%
Top 10 Hldgs %
37.93%
Holding
179
New
31
Increased
24
Reduced
59
Closed
46

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$45.5M
2
VSAT icon
Viasat
VSAT
+$39.5M
3
TMUS icon
T-Mobile US
TMUS
+$29.3M
4
TDG icon
TransDigm Group
TDG
+$22.7M
5
STWD icon
Starwood Property Trust
STWD
+$20.2M

Sector Composition

Rank Sector Weight
1 Technology 19.84%
2 Financials 19.35%
3 Healthcare 18.47%
4 Consumer Discretionary 14.53%
5 Real Estate 12.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GBDC icon
26
Golub Capital BDC
GBDC
$3.23B
$18.5M 1.28%
985,537
ALXN
27
DELISTED
Alexion Pharmaceuticals
ALXN
$17.3M 1.2%
141,859
+17,159
+14% +$2M
LEN icon
28
Lennar Class A
LEN
$19.3B
$15.4M 1.07%
304,029
-9,857
-3% -$485K
BIIB icon
29
Biogen
BIIB
$31.9B
$14.4M 1%
53,222
-3,122
-6% -$826K
LADR
30
Ladder Capital
LADR
$1.21B
$14.3M 0.99%
1,063,978
-12,200
-1% -$175K
CELG
31
DELISTED
Celgene Corp
CELG
$14.1M 0.98%
108,747
+10,747
+11% +$1.32M
BIDU icon
32
Baidu
BIDU
$30.8B
$14M 0.97%
78,474
+3,944
+5% +$715K
LOGM
33
DELISTED
LogMein, Inc.
LOGM
$13.6M 0.95%
130,534
-14,300
-10% -$1.57M
VIPS icon
34
Vipshop
VIPS
$5.75B
$13.6M 0.95%
+1,290,858
New +$16.9M
ELLI
35
DELISTED
Ellie Mae Inc
ELLI
$13.2M 0.92%
120,300
-3,700
-3% -$400K
CORV
36
DELISTED
Correvio Pharma Corp. Ordinary Shares (Canada)
CORV
$13M 0.9%
2,878,985
-79,430
-3% -$288K
CRSP icon
37
CRISPR Therapeutics
CRSP
$5.01B
$12.8M 0.89%
797,231
-27,633
-3% -$456K
LRCX icon
38
Lam Research
LRCX
$339B
$12.2M 0.85%
+865,000
New +$12.7M
MTGE
39
DELISTED
MTGE Investment Corp. Common Stock
MTGE
$12.2M 0.85%
649,465
-22,000
-3% -$398K
PFE icon
40
Pfizer
PFE
$157B
$12.2M 0.84%
381,232
BIVV
41
DELISTED
Bioverativ Inc. Common Stock
BIVV
$11.8M 0.82%
+196,200
New +$11.2M
AMZN icon
42
Amazon
AMZN
$2.68T
$11.7M 0.81%
+241,100
New +$11.5M
NUVA
43
DELISTED
NuVasive, Inc.
NUVA
$11.5M 0.8%
+149,300
New +$11.2M
HOLX
44
DELISTED
Hologic
HOLX
$9.98M 0.69%
219,848
-216,052
-50% -$9.54M
WELL icon
45
Welltower
WELL
$168B
$9.49M 0.66%
126,800
-128,800
-50% -$9.42M
CRM icon
46
Salesforce
CRM
$210B
$9.08M 0.63%
104,900
-24,600
-19% -$2.14M
AGN
47
DELISTED
Allergan plc
AGN
$8.85M 0.61%
+36,400
New +$8.55M
LITE icon
48
Lumentum
LITE
$75.3B
$8.83M 0.61%
154,800
+45,034
+41% +$2.41M
VRTX icon
49
Vertex Pharmaceuticals
VRTX
$130B
$8.3M 0.58%
64,382
-110,766
-63% -$13.3M
SCI icon
50
Service Corp International
SCI
$11.1B
$7.72M 0.54%
230,868
-83,664
-27% -$2.67M

Similar funds

Clough Capital Partners's Q2 2017 Portfolio in Review

As of Q2 2017, Clough Capital Partners held 179 positions worth $1.44B, down 8.5% from $1.58B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Clough Capital Partners withdrew a net $187M in Q2 2017, closing 46 positions and reducing 59 holdings. Its most notable exit was T-Mobile US, an estimated $29.3M position sold in full.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 23% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Clough Capital Partners opened a new position in Meta Platforms (Facebook) worth $30.3M.

  • Clough Capital Partners's largest Q2 2017 buy was Meta Platforms (Facebook): 200,400 shares worth $30.3M.
  • Clough Capital Partners added most to Citigroup in Q2 2017, an estimated $12.2M increase.
  • Clough Capital Partners's biggest Q2 2017 reduction was Apple, cutting an estimated $45.5M.
  • Clough Capital Partners fully exited T-Mobile US in Q2 2017, selling an estimated $29.3M.
  • Clough Capital Partners's ten largest holdings make up 38% of its $1.44B portfolio in Q2 2017.
  • Clough Capital Partners opened 31 new positions and closed 46 in Q2 2017.
  • Clough Capital Partners's portfolio value fell 8.5% quarter-over-quarter to $1.44B.

Based on Clough Capital Partners's 13F filing for Q2 2017, filed 14 Aug 2017.